Tribble Jacob T, Pfeiffer Ruth M, Brownell Isaac, Cahoon Elizabeth K, Sargen Michael R, Shiels Meredith S, Luo Qianlai, Cohen Colby, Drezner Kate, Hernandez Brenda, Moreno Adrianne, Pawlish Karen, Saafir-Callaway Brittani, Engels Eric A, Volesky-Avellaneda Karena D
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland.
JAMA Dermatol. 2025 Jan 1;161(1):47-55. doi: 10.1001/jamadermatol.2024.4607.
Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer. Quantifying the contribution of major potentially modifiable risk factors to the burden of MCC may inform prevention efforts.
To estimate the population attributable fraction of MCC cases in the US that were attributable to major immunosuppressing conditions (eg, HIV, solid organ transplant, chronic lymphocytic leukemia [CLL]), ambient UV radiation [UVR] exposure, and Merkel cell polyomavirus [MCPyV]).
DESIGN, SETTING, AND PARTICIPANTS: This epidemiological assessment combined data from population-based registries and case series and included cases of MCC that were diagnosed from January 2001 to December 2019 diagnosed in people with HIV, solid organ transplant recipients, and patients with CLL who were identified through population-based cancer registries and linkages with HIV and transplant registries. UVR-based on cloud-adjusted daily ambient UVR irradiance was merged with cancer registry data on the county of residence at diagnosis. Studies reporting the prevalence of MCPyV in MCC specimens collected in the US were combined via a meta-analysis.
HIV, solid organ transplant, CLL, UVR, and MCPyV.
Population attributable fraction of MCC cases attributable to major risk factors.
A total of 38 020 MCCs were diagnosed in the US among xx patients (14 325 [38%] female individuals; 1586 [4%] Hispanic, 561 [1%] non-Hispanic Black, and 35 171 [93%] non-Hispanic White individuals). Compared with the general US population, MCC incidence was elevated among people with HIV (standardized incidence ratio [SIR], 2.78), organ transplant recipients (SIR, 13.1), and patients with CLL (SIR, 5.75). Due to the rarity of these conditions, only 0.2% (95% CI, 0.1%-0.3%) of MCC cases were attributable to HIV, 1.5% (95% CI, 1.4%-1.7%) to solid organ transplant, and 0.8% (95% CI, 0.5%-1.3%) to CLL. Compared with individuals of racial and ethnic minority groups, MCC incidence was elevated among non-Hispanic White individuals at lower and higher ambient UVR exposure levels (incidence rate ratios: 4.05 and 4.91, respectively, for MCC on the head and neck). Overall, 65.1% (95% CI, 63.6%-66.7%) of MCCs were attributable to UVR. Based on a meta-analysis of 19 case series, 63.8% (95% CI, 54.5%-70.9%) of MCCs were attributable to MCPyV. Studies were identified from a MEDLINE search performed on October 12, 2023.
The results of this study suggest that most MCC cases in the US were attributable to ambient UVR exposure or MCPyV, with a small fraction due to immunosuppressive conditions. Efforts to lower MCC incidence could focus on limiting UVR exposure.
默克尔细胞癌(MCC)是一种罕见但侵袭性强的皮肤癌。量化主要潜在可改变风险因素对MCC负担的贡献可能为预防工作提供依据。
估计美国因主要免疫抑制状况(如艾滋病毒、实体器官移植、慢性淋巴细胞白血病[CLL])、环境紫外线辐射[UVR]暴露和默克尔细胞多瘤病毒[MCPyV])导致的MCC病例的人群归因分数。
设计、设置和参与者:这项流行病学评估结合了基于人群的登记处和病例系列的数据,包括2001年1月至2019年12月诊断的MCC病例,这些病例来自通过基于人群的癌症登记处以及与艾滋病毒和移植登记处的关联而识别出的艾滋病毒感染者、实体器官移植受者和CLL患者。基于云调整的每日环境UVR辐照度的UVR数据与诊断时居住县的癌症登记数据合并。通过荟萃分析合并了报告美国收集的MCC标本中MCPyV患病率的研究。
艾滋病毒、实体器官移植、CLL、UVR和MCPyV。
主要风险因素导致的MCC病例的人群归因分数。
在美国,xx名患者中共诊断出38020例MCC(14325名[38%]女性;1586名[4%]西班牙裔、561名[1%]非西班牙裔黑人、35171名[93%]非西班牙裔白人)。与美国普通人群相比,艾滋病毒感染者中的MCC发病率升高(标准化发病率比[SIR],2.78),器官移植受者(SIR,13.1)和CLL患者(SIR,5.75)。由于这些情况罕见,仅0.2%(95%CI,0.1%-0.3%)的MCC病例归因于艾滋病毒,1.5%(95%CI,1.4%-1.7%)归因于实体器官移植,0.8%(95%CI,0.5%-1.3%)归因于CLL。与少数种族和族裔群体的个体相比,在较低和较高环境UVR暴露水平下,非西班牙裔白人个体中的MCC发病率升高(发病率比:头部和颈部MCC分别为4.05和4.91)。总体而言,65.1%(95%CI,63.6%-66.7%)的MCC归因于UVR。基于对19个病例系列的荟萃分析,63.8%(95%CI,54.5%-70.9%)的MCC归因于MCPyV。研究是从2023年10月12日进行的MEDLINE搜索中识别出来的。
本研究结果表明,美国大多数MCC病例归因于环境UVR暴露或MCPyV,一小部分归因于免疫抑制状况。降低MCC发病率的努力可侧重于限制UVR暴露。